Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Minerva Cardioangiologica|July 1, 1996
[Short- and long-term evaluation of treatment of critical ischemia of the lower lim with PGE1 (alprostadyl alpha-cyclodestrine)]M Amitrano, M Izzo, G Castaldo, et al.
Letters in Applied Microbiology|March 5, 2002
Detection and potential indicators of the presence of hepatitis C virus on surfaces in hospital settingsAnnalaura Carducci, M Verani, B Casini, et al.
The Journal of Hospital Infection|August 30, 2008
Evaluation of contamination by blood aerosols produced during various healthcare proceduresF Perdelli, A M Spagnolo, M L Cristina, et al.
International Journal of Cardiology|January 3, 1997
Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimensG L Botto, A Capucci, W Bonini, et al.
The American Journal of Cardiology|September 25, 1999
Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic functionC Briguori, S Betocchi, M Romano, et al.
Chemical Communications (Cambridge, England)|December 21, 2010
Scanned chemical enhancement of surface-enhanced Raman scattering using a charge-transfer complexWei Ji, Xiangxin Xue, Weidong Ruan, et al.
Injury Epidemiology|August 12, 2024
Implications of using administrative healthcare data to identify risk of motor vehicle crash-related injury: the importance of distinguishing crash from crash-related injuryNina R Joyce, Leah R Lombardi, Melissa R Pfeiffer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
Administration of voriconazole in patients with renal dysfunctionDionissios Neofytos, Lindsey R Lombardi, Ryan K Shields, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 26, 2011
A retrospective analysis of the effect of patient-specific factors on voriconazole concentrations in oncology patientsLindsey R Lombardi, Todd A Miano, Jennifer L Davis, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 24, 1998
A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activityA M Soares, V M Rodrigues, M I Homsi-Brandeburgo, et al.
Pageof 18